Literature DB >> 17143176

Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region.

Alexandra L C Martiniuk1, Crystal M Y Lee, Carlene M M Lawes, Hirotsugu Ueshima, Il Suh, Tai Hing Lam, Dongfeng Gu, Valery Feigin, Konrad Jamrozik, Takayoshi Ohkubo, Mark Woodward.   

Abstract

OBJECTIVE: About half of the world's burden of cardiovascular disease is carried by countries in the Asia-Pacific region. This study aimed to quantify the contribution of hypertension to cardiovascular diseases (CVD) at the country level, by calculating the sex-specific, population-attributable fractions (PAFs) for fatal ischaemic heart disease (IHD) and stroke (haemorrhagic and ischaemic) for the World Health Organization Western Pacific and South-east Asian regions.
METHODS: The most recent sex-specific prevalence data on hypertension were sought. Age-adjusted hazard ratio (HR) estimates for fatal IHD and stroke associated with hypertension were obtained using Cox analyses of individual participant cohort data from 600,000 adult participants in the Asia-Pacific Cohort Studies Collaboration. HR estimates and prevalence were then used to calculate sex-specific PAFs for fatal IHD and stroke, by country.
RESULTS: In 15 countries with available data, the prevalence of hypertension ranged from 5-47% in men and from 7-38% in women. Overall, the fraction of IHD attributable to hypertension ranged from 4-28% in men and from 8-39% in women. Corresponding ranges for haemorrhagic stroke were 18-66% and 15-49%, and for ischaemic stroke were 8-44% and 12-45%.
CONCLUSIONS: In the Asia-Pacific region, up to 66% of some subtypes of CVD can be attributed to hypertension, underscoring the immense impact that blood pressure- lowering strategies could have in this populous region.

Entities:  

Mesh:

Year:  2007        PMID: 17143176     DOI: 10.1097/HJH.0b013e328010775f

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  60 in total

1.  Association of Blood Pressure Classification in Korean Young Adults According to the 2017 American College of Cardiology/American Heart Association Guidelines With Subsequent Cardiovascular Disease Events.

Authors:  Joung Sik Son; Seulggie Choi; Kyuwoong Kim; Sung Min Kim; Daein Choi; Gyeongsil Lee; Su-Min Jeong; Seong Yong Park; Yeon-Yong Kim; Jae-Moon Yun; Sang Min Park
Journal:  JAMA       Date:  2018-11-06       Impact factor: 56.272

2.  Comparison of Mass Versus Activity of Creatine Kinase MB and Its Utility in the Early Diagnosis of Re-infarction.

Authors:  Simbita A Marwah; Hitesh Shah; Kiran Chauhan; Amit Trivedi; N Haridas
Journal:  Indian J Clin Biochem       Date:  2013-05-15

3.  Genetic variants in the renin-angiotensin system and blood pressure reactions to the cold pressor test.

Authors:  Laiyuan Wang; Liping Hou; Hongfan Li; Jing Chen; Tanika N Kelly; Cashell E Jaquish; Dabeeru C Rao; James E Hixson; Dongsheng Hu; Chung-Shiuan Chen; Charles Gu; Shufeng Chen; Xiangfeng Lu; Paul K Whelton; Jiang He; Fanghong Lu; Jianfeng Huang; De-Pei Liu; Dongfeng Gu
Journal:  J Hypertens       Date:  2010-12       Impact factor: 4.844

4.  Association of multimodal treatment-induced improvements in stress, exercise volume, nutrition, and weight with improved blood pressure in severely obese women.

Authors:  James J Annesi
Journal:  Int J Behav Med       Date:  2013-09

5.  Potent and Selective Inhibitors of Long Chain l-2-Hydroxy Acid Oxidase Reduced Blood Pressure in DOCA Salt-Treated Rats.

Authors:  Dinesh A Barawkar; Ashwin Meru; Anish Bandyopadhyay; Abir Banerjee; Anil M Deshpande; Chandrashekhar Athare; Chandrasekhar Koduru; Goraksha Khose; Jayasagar Gundu; Koshu Mahajan; Pradeep Patil; Sachin R Kandalkar; Sanjay Niranjan; Shubhangi Bhosale; Siddhartha De; Sudit Mukhopadhyay; Sumit Chaudhary; Summon Koul; Umesh Singh; Anita Chugh; Venkata P Palle; Kasim A Mookhtiar; Joseph Vacca; Prasun K Chakravarty; Ravi P Nargund; Samuel D Wright; Sophie Roy; Michael P Graziano; Sheo B Singh; Doris Cully; Tian-Quan Cai
Journal:  ACS Med Chem Lett       Date:  2011-10-07       Impact factor: 4.345

6.  Efficacy and tolerability of long-acting nifedipine GITS/OROS monotherapy or combination therapy in hypertensive patients: results of a 12-week international, prospective, multicentre, observational study.

Authors:  Kwo-Chang Ueng; Sun Ningling; Abd El Maksod; Kuan-Yu Hung; Yin Yuehui
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

7.  Primary coronary intervention for ST-elevation myocardial infarction in Indonesia and the Netherlands: a comparison.

Authors:  Y B Juwana; J Wirianta; J P Ottervanger; J H E Dambrink; A W J van 't Hof; A T M Gosselink; J Hoorntje; M J de Boer; H Suryapranata
Journal:  Neth Heart J       Date:  2009-11       Impact factor: 2.380

Review 8.  Heart failure in hypertension: prevention and treatment.

Authors:  Vasiliki V Georgiopoulou; Andreas P Kalogeropoulos; Javed Butler
Journal:  Drugs       Date:  2012-07-09       Impact factor: 9.546

9.  Relation of blood pressure components and categories and all-cause, stroke and coronary heart disease mortality in urban Chinese women: a population-based prospective study.

Authors:  Tsogzolmaa Dorjgochoo; Xiao Ou Shu; Xianglan Zhang; Honglan Li; Gong Yang; Lifeng Gao; Hui Cai; Yu-Tang Gao; Wei Zheng
Journal:  J Hypertens       Date:  2009-03       Impact factor: 4.844

Review 10.  Cardiovascular disease and risk factors in Asia: a selected review.

Authors:  Hirotsugu Ueshima; Akira Sekikawa; Katsuyuki Miura; Tanvir Chowdhury Turin; Naoyuki Takashima; Yoshikuni Kita; Makoto Watanabe; Aya Kadota; Nagako Okuda; Takashi Kadowaki; Yasuyuki Nakamura; Tomonori Okamura
Journal:  Circulation       Date:  2008-12-16       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.